Synonyms: Daonil; Diabeta; HB-420; Glibenclamid Basics; Glibenclamid-Cophar; Glibenclamid Heumann; Semi-Euglucon; Glibenclamid Genericon; Hemi-Daonil; Glibenclamid-Ratiopharm; Glibenclamidum [INN-Latin]; Glibenclamida [INN-Spanish]; Abbenclamide; HB419; HB 419; Diabiphage; Glibadone; Semi-Gliben-Puren N; GBN 5; Glibenclamid Riker M.; Glyburide (micronized); 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide; UR 606; Glycron; HB420; glyburide (glibenclamide); UNII-SX6K58TVWC; 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; C23H28ClN3O5S; HB-419; 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide; U 26452; EINECS 233-570-6; MFCD00056625; Maninil; SX6K58TVWC; CHEMBL472; BRN 2230085; N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea; MLS000069721; CHEBI:5441; 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide; Urea, 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexyl-; Benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-; NCGC00015467-11; Micronase; SMR000058229; CAS-10238-21-8; 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide; Euglucon N; Urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl-; 5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide; 5-chloro-N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-2-methoxybenzamide; DSSTox_CID_17237; DSSTox_RID_79313; N-(4-(beta-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff; Neogluconin; DSSTox_GSID_37237; Benzamide, 5-chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxy-; Micronized glyburide; Glyburide [USAN]; W-108874; Glimidstata; Glycolande; PresTab; Gluco-Tablimen; Dia-basan; Glibenclamide; 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea; Gliben-Puren N; 5-chloro-N-(2-{4-[N-(N-cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide; Glyburide (USP); Micronase (TN); 1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea;1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea; Diabeta (TN); Glynase (TN); GIBENCLAMIDE; Glibenclamid Riker M; glyburide; SR-01000000196; Glyburide [USAN:USP]; HB-420; Amglidia; Delmide; Glyburide(Diabeta); Glibenclamide,(S); GBM; Prestwick_569; Glibenclamide B.P.; 10238-21-8; Glyburide (Diabeta); Glibenclamide [INN]; RP-1127; Spectrum_000250; Tocris-0911; Glybenzcyclamide, 99%; Opera_ID_801; Prestwick0_000316; Prestwick1_000316; Prestwick2_000316; Glybenclamide; Prestwick3_000316; Spectrum2_001816; Spectrum3_001327; Spectrum4_001199; Spectrum5_001631; Lopac-G-0639; ACMC-20a66i; Probes1_000431; Probes2_000378; UPCMLD-DP006; Euglucon 5; Micronase; G 0639; AC1L1G1Q; Glibenclamide (JP17/INN); CBiol_001790; Lopac0_000499; Oprea1_764617; SCHEMBL22009; U-26452; BSPBio_000312; BSPBio_001351; Diabeta; BSPBio_003053; KBioGR_000071; KBioGR_001897; KBioSS_000071; KBioSS_000730; MLS001077262; BIDD:GT0239; DivK1c_000481; SPECTRUM2300229; SPBio_001831; Glynase; SPBio_002531; AC1Q44V7; BPBio1_000344; GTPL2414; DTXSID0037237; UPCMLD-DP006:001; CTK8B7917; HMS501I03; KBio1_000481; KBio2_000071; Daonil; KBio2_000730; KBio2_002639; KBio2_003298; KBio2_005207; KBio2_005866; KBio3_000141; KBio3_000142; KBio3_002273; AOB6214; SYN3026; Euglucon; Glybenclamide, >=99% (HPLC); NINDS_000481; ZNNLBTZKUZBEKO-UHFFFAOYSA-N; Bio1_000076; Bio1_000565; Bio1_001054; Bio2_000071; Bio2_000551; HMS1361D13; HMS1568P14; Maninil; HMS1791D13; HMS1922L08; HMS1989D13; HMS2089L06; HMS2093P04; HMS2095P14; HMS3259O12; HMS3261D19; HMS3267A15; HMS3402D13; Semi-daonil; HMS3428D15; HMS3651E17; HMS3675F16; HMS3712P14; Pharmakon1600-02300229; ZINC537805; BCP05327; Tox21_110158; Tox21_300758; Tox21_500499; Apo-Glibenclamide; ANW-58936; BDBM50012957; BG0207; CCG-39618; GP8701; HD 419; NSC759618; SBB057426; STK362992; AKOS001487495; Euglucon 5; N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea; Tox21_110158_1; BCP9000729; CS-1075; DB01016; KS-5326; LP00499; MCULE-2351642942; NC00566; NSC-759618; Azuglucon; SB17414; IDI1_000481; IDI1_033821; Glibenclamide 1.0 mg/ml in Acetonitrile; NCGC00015467-01; NCGC00015467-02; NCGC00015467-03; NCGC00015467-04; NCGC00015467-05; NCGC00015467-06; Euglucon N; Bastiverit; NCGC00015467-07; NCGC00015467-08; NCGC00015467-09; NCGC00015467-10; NCGC00015467-12; NCGC00015467-13; NCGC00015467-14; NCGC00015467-15; NCGC00015467-16; NCGC00015467-17; Benclamin; NCGC00015467-18; NCGC00015467-20; NCGC00015467-36; NCGC00016689-01; NCGC00023447-02; NCGC00023447-04; NCGC00023447-05; NCGC00023447-06; NCGC00023447-07; NCGC00023447-08; Betanase; NCGC00023447-09; NCGC00023447-10; NCGC00023447-11; NCGC00023447-12; NCGC00254662-01; NCGC00261184-01; 5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide; AJ-23371; AN-20367; CPD000058229; Duraglucon; HY-15206; SAM002564212; SC-17437; ST024780; SBI-0050483.P003; AB0012611; AB2000243; Glyburide, meets USP testing specifications; LS-159295; RT-000122; Euglucan; AB00051949; EU-0100499; FT-0601608; G-150; G0382; S1716; SW195828-5; A19539; C07022; D00336; Euglykon; J10021; W-5054; 78637-EP2270001A1; 78637-EP2270011A1; 78637-EP2272825A2; 78637-EP2272841A1; 78637-EP2275414A1; 78637-EP2287165A2; 78637-EP2287166A2; 78637-EP2292620A2; Glibenil; 78637-EP2298750A1; 78637-EP2298776A1; 78637-EP2298779A1; 78637-EP2301923A1; 78637-EP2301936A1; 78637-EP2305648A1; 78637-EP2308847A1; AB00051949-16; AB00051949-17; AB00051949_18; Glucolon; AB00051949_19; C-22898; I06-0716; SR-01000000196-2; SR-01000000196-4; SR-01000000196-5; SR-01000000196-6; SR-01000000196-8; U-26,452; BRD-K36927236-001-06-0; Neogluconin; BRD-K36927236-001-17-7; Z277540138; Glybenclamide, European Pharmacopoeia (EP) Reference Standard; Glyburide, United States Pharmacopeia (USP) Reference Standard; 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl urea; 5-Chloro-N-[4-(3-cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide; 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)-phenethyl)-2-methoxybenzamide; 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide; 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide.; 5-chloro-N-[4-({[(cyclohexylamino)carbonyl]amino}sulfonyl)phenethyl]-2-methoxybenzamide; Orabetic; Glibenclamide for peak identification, European Pharmacopoeia (EP) Reference Standard; Glyburide (Glibenclamide), Pharmaceutical Secondary Standard; Certified Reference Material; N-(4-(.beta.-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff; N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea; N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N'-cyclohexylurea; (5-chloro-2-methoxyphenyl)-N-[2-(4-{[(cyclohexylamino)carbonylamino]sulfonyl}p henyl)ethyl]carboxamide; 5-Chloro-N-(2-[4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-2-methoxybenzamide #; 5-Chloro-N-[2-[4-[[[(Cylcohexylamino)carbonyl]amino]sulphonyl]phenyl]ethyl]-2-methoxybenzamide; N-[(4-{2-[(5-chloro-2-methoxyphenyl)carbonylamino]ethyl}phenyl)sulfonyl](cyclo hexylamino)carboxamide; glicuformine; Glibenclamide; Prodiabet; Glucovance; Malix; Euglucon (TN); Daonil (TN); Semi-Daonil (TN); D05LYX; Glibenclamide (JP15/INN); HB419; HB420; CID3488; Renabetic; HB 420; C23-H28-Cl-N3-O5-S; Glyburide, 98% - 100G 100g; ACN-048745; CS-O-01584; B1296; B1948; A10433; D005905; Benzamide, 5-chloro-N-[2-[4-[[[(cyclohexylamino) carbonyl]amino]sulfonyl]phenyl]ethyl] -2-methoxy-; Yuglucon; Urea, 1-[[p-[2-(5-chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexyl-; Glibenclamide;Glycron;Glynase;Micronase;Daonil;Semi-Daonil;Euglucon;Delmide;Diabeta; N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N-cyclohexylurea; 5-Chloro-N-[2-[4-[[[(cy-clohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide; Benzamida, 5-cloro-N-[2-[4-[[[( ciclohexilamino) carbonil] amino] sulfonil] fenil] etil]-2-metoxi-; Dibelet; Gilemal; Glibens; Glibil; Glimel; Glimide; Humedia; Glybenclamide; Libanil; Suraben; Tiabet; Adiab; Glybenzcyclamide; Melix; Pira; Med-Glionil; Gewaglucon; Glibenbeta; Glyburide; Glibenclamida; Glibenclamidum; Glucohexal; Glucoremed; Hexaglucon; Lisaglucon; Normoglucon; Praeciglucon; Calabren; Cytagon; HB 419; Euclamin; Glamide; Glibesyn; Glibetic; Gliboral; Glidiabet; Glisulin; Glitisol; Glubate; Glucobene; HB 420; Glucomid; Glucoven; Glycomin; Lederglib; Miglucan; Debtan; Gliban; Gliben; Glibet; Glicem; HB-419; Gluben; Glyben; Nadib; Sugril; Novo-Glyburide; Glibenclamid AL; Gen-Glybe; Norglicem 5; Betanese 5; Glibenclamid Fabra;